(Q36634455)

15 August 2017

title

Management of recurrent vulvovaginal candidiasis: unresolved issues (English)

1 reference

15 August 2017

1 reference

vulvovaginal candidiasis

1 reference

1

Jack D Sobel

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Current infectious disease reports

15 August 2017

published in

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

481-486

1 reference

Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-006-0023-7

Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-006-0023-7

Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-006-0023-7

Vaginal Candida parapsilosis: pathogen or bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-006-0023-7

Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment

21 January 2018

1 reference

12 December 2020

Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy.

1 reference

12 December 2020

Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine

1 reference

12 December 2020

The epidemiology of vulvovaginal candidiasis: risk factors

1 reference

12 December 2020

History and new insights into host defense against vaginal candidiasis

1 reference

12 December 2020

Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy

1 reference

12 December 2020

Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis

1 reference

12 December 2020

Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis

1 reference

12 December 2020

Pathogenesis of Recurrent Vulvovaginal Candidiasis

1 reference

12 December 2020

Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy

1 reference

12 December 2020

Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals

1 reference

12 December 2020

Hyposensitisation in the management of recurring vaginal candidiasis

1 reference

12 December 2020

Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium

1 reference

12 December 2020

Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis

1 reference

12 December 2020

Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications

1 reference

12 December 2020

Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases

1 reference

12 December 2020

Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole

1 reference

12 December 2020

10.1007/S11908-006-0023-7

Identifiers

DOI

1 reference

15 August 2017

1 reference